Detalhe da pesquisa
1.
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.
Mult Scler
; 30(6): 707-713, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38456445
2.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Eur J Neurol
; 31(6): e16250, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38549186
3.
Comparing face-to-face and videoconference assessment of the Brief Repeatable Battery of Neuropsychological Tests in people with multiple sclerosis.
Mult Scler
; 29(10): 1337-1339, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37602442
4.
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?
Eur J Neurol
; 30(8): 2357-2364, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37154406
5.
Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.
Mult Scler
; 28(1): 93-101, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33855897
6.
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.
Mult Scler
; 28(13): 2106-2111, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35735030
7.
A real-world study of alemtuzumab in a cohort of Italian patients.
Eur J Neurol
; 29(1): 257-266, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34558755
8.
Therapeutic Plasmapheresis: a revision of literature.
Kidney Blood Press Res
; 2022 Dec 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36481657
9.
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case-control study.
Neurol Sci
; 43(4): 2601-2609, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34561786
10.
Disability assessment using Google Maps.
Neurol Sci
; 43(2): 1007-1014, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34142263
11.
Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families.
Int J Mol Sci
; 22(7)2021 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33807278
12.
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience.
Mult Scler
; 26(12): 1519-1531, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31573386
13.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Neurol Sci
; 41(10): 2905-2913, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32335779
14.
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.
Mult Scler
; 25(9): 1263-1272, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30044207
15.
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests.
Mult Scler
; 23(9): 1289-1296, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27811338
16.
Correction to: Disability assessment using Google Maps.
Neurol Sci
; 43(2): 1481, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34727256
17.
The multidimensional assessment of body representation and interoception in multiple sclerosis.
Mult Scler Relat Disord
; 87: 105692, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38810419
18.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study.
J Neurol
; 2024 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38704488
19.
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8+ T-Cell Proliferation in Patients With Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 11(4): e200250, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38662990
20.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Mult Scler Relat Disord
; 87: 105594, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38718748